Genetic Modifiers of Liver Disease in Cystic Fibrosis
Supplementary Online Content Bartlett JR, Friedman KJ, Ling SC, et al; Gene Modifier Study Group. Genetic modifiers of liver disease in cystic fibrosis. JAMA. 2009;302(10):1076-1083. eSupplement. The Gene Modifier Study Group This supplementary material has been provided by the authors to give readers additional information about their work. © 2009 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/24/2021 eSupplement. The Gene Modifier Study Group Participating Groups: Alabama: University of Alabama at Birmingham (J.P. Clancy); Pulmonary Associates, Mobile (L.J. Sindel). Alaska: Providence Alaska Medical Center, Anchorage (D.M. Roberts, V. Roberts); Arizona: Phoenix Children’s Hospital, Phoenix (P.J. Radford, N. Argel); University of Arizona, Tucson (W.J. Morgan, J.L. Douthit). Arkansas: University of Arkansas Medical Sciences, Little Rock (D.E. Schellhase, P. Anderson, A. Taggart). California: University of California, Davis, School of Medicine (B. Morrissey); Children’s Hospital of LA, Los Angeles (A.C.G. Platzker, M.S. Woo, L. Fukushima, E. Hsu); Northern California Kaiser Permanente Medical Care Program, Oakland (G.F. Shay); Bay Area Pediatric Pulmonary, Oakland (K.A. Hardy); Lucile Packard Children’s Hospital, Stanford University Medical Center, Palo Alto (R.B. Moss, C. E. Dunn); University of California-San Diego, Children’s Hospital (M.S. Pian); Naval Medical Center, San Diego (H.A. Wojtczak, L. Burns); California Pacific Medical Center, San Francisco (N.R. Henig); University of California, San Francisco (D.W. Nielson); Ventura County Medical Center, Ventura (C. Landon, A. Thompson). Colorado: Denver Children’s Hospital, Denver (F.J. Accurso); University of Colorado Adult Cystic Fibrosis Program, Denver (J.A.
[Show full text]